Search - tctmd.com

Displaying 1 - 20 of 237

Sort: Relevancy | Date

FDA Expands Evolut Indication to Include Redo TAVI

News Daily News

FDA Expands Evolut Indications to Include Redo TAVI

Yael L. Maxwell

August 29, 2025

News Daily News

FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis

Michael O'Riordan

May 01, 2025

News Conference News ACC 2025

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

Michael O'Riordan

March 30, 2025

News Industry News

Pi-Cardia Reports First Commercial Cases with ShortCut™

March 03, 2025

News Daily News

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

Yael L. Maxwell

February 20, 2025

News Opinion CV Team Dispatch

January 2025 Dispatch for the CV Team

L.A. McKeown

January 24, 2025

News Daily News

Top Structural Heart News of 2024

L.A. McKeown

December 29, 2024

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Todd Neale

October 30, 2024

News Conference News TCT 2024

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

Yael L. Maxwell

October 29, 2024

News Industry News

Pi-Cardia Receives FDA Market Clearance for ShortCut™

October 01, 2024

News Features

Valvular Heart Disease Has a Diversity Problem

Yael L. Maxwell

July 12, 2024

News Opinion CV Team Dispatch

July 2024 Dispatch for the CV Team

L.A. McKeown

July 01, 2024

News Conference News STS 2024

TAVI, SAVR Almost Equally Performed in California Patients Under 60

Yael L. Maxwell

February 01, 2024

News Daily News

Abbott to Stop Making Trifecta Surgical Aortic Valves

Michael O'Riordan

July 31, 2023

News Daily News

Women and Minorities Underrepresented in Heart Valve Trials

L.A. McKeown

July 27, 2023

News Conference News EuroPCR 2023

Five-Year PORTICO IDE Data Reassure on Outcomes, Hemodynamics

Michael O'Riordan

May 17, 2023

News Daily News

FDA Alert: Possible Early Deterioration of Abbott Trifecta SAVR Valves

Todd Neale

February 27, 2023

News Daily News

FDA: Endologix AAA Grafts Get New Labeling That Addresses Endoleak Potential

L.A. McKeown

December 06, 2022

News Daily News

LivaNova Recalls Some LifeSPARC Controllers Used in Advanced Circulatory Support

L.A. McKeown

September 30, 2022

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

Advertisement

FDA Expands Evolut Indications to Include Redo TAVI

FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

Pi-Cardia Reports First Commercial Cases with ShortCut™

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

January 2025 Dispatch for the CV Team

Top Structural Heart News of 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

Pi-Cardia Receives FDA Market Clearance for ShortCut™

Valvular Heart Disease Has a Diversity Problem

July 2024 Dispatch for the CV Team

TAVI, SAVR Almost Equally Performed in California Patients Under 60

Abbott to Stop Making Trifecta Surgical Aortic Valves

Women and Minorities Underrepresented in Heart Valve Trials

Five-Year PORTICO IDE Data Reassure on Outcomes, Hemodynamics

FDA Alert: Possible Early Deterioration of Abbott Trifecta SAVR Valves

FDA: Endologix AAA Grafts Get New Labeling That Addresses Endoleak Potential

LivaNova Recalls Some LifeSPARC Controllers Used in Advanced Circulatory Support

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content